Reprogramming temozolomide response in glioblastoma through regulated and immunogenic cell death modalities
26 May 2026 at 08:00
Cell Death Discovery, Published online: 26 May 2026; doi:10.1038/s41420-026-03151-6
Reprogramming temozolomide response in glioblastoma through regulated and immunogenic cell death modalities